focus -WSS

focus

author：comprehensive 2025-10-01 23:04:16 - browse：5

light shines behind Pfizer CEO Albert Bourla as he attends a ceremony in Greece — Pfizer CEO Albert Bourla was one of a few pharmaceutical executives who donated to a failed Senate campaign in New Jersey. Giannis Papanikos/AP

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.

Administration infighting over the national stockpile

The health department’s preparedness office overseeing national stockpiles of emergency medical gear is trying to cement its Covid-era power — and meeting with congressional skepticism.

The Administration for Strategic Preparedness and Response has seen demands for protective gear and therapies rapidly expand between the Covid-19 pandemic, the 2022 mpox outbreak, and now the spread of avian flu among cows. But its management of the nation’s medical stockpile — and its efforts to replenish depleting stock — are under fresh scrutiny from lawmakers. In particular, Republicans want answers on the $850 million that Congress clawed back from ASPR’s budget, and on why that cash wasn’t spent if the stockpile needed it so badly, my co-author Sarah Owermohle reports.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Flu vaccine reformulation won't be easy, manufacturers warn

WSS

FDA early review: GLP

Male doctors called my cancer incurable. A female doctor showed it wasn't

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

FDA endorses new sterilization method for medical devices

Life science postdocs should get big pay hike, NIH panel says

To bolster infectious disease surveillance, genomics powerhouses team up

knowledge

focus

Administration infighting over the national stockpile

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

explore

After affirmative action ruling, medical educators look to 'holistic review'

Microsoft launches AI tool for clinical documentation through Epic

Supreme Court strikes down use of affirmative action

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

ChatGPT in medicine: STAT answers readers' burning questions

Boston Scientific acquires urology company Axonics for $3.7 billion

Medical leaders decry Supreme Court decision on affirmative action

Prior authorization reform is both possible and imperative

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

hotspot

Printout prescription drug information shouldn’t go digital

In shift, Texas to cover initial consult for Afghan baby's gene therapy

There's an unseen cost to disruptive road

Physician assistants need a new name. Here's what it should be

A preacher's new calling: Diversifying neuroscience research

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

Wikipedia

focus

entertainment

explore